~~<i id='610076D968'><strike id='610076D968'><tt id='610076D968'><pre id='610076D968'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：hotspot 2025-08-11 07:59:32 - browse：9525

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Sanofi strikes deal with Novavax, boosting the vaccine maker

Wikipedia

leisure time

entertainment

leisure time

hotspot

explore

AdobeIt’snosecretthataluckyfewseemtoglideintooldage,theyearssettlinggracefullyontheirbodies,whileoth

WSS

Snackable artificial intelligence, expert AI, and the pharma industry

H5N1 communication has been strictly for the birds

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Making AI in medicine accessible to smaller, and rural hospitals

Humana sues Biden admin over Medicare Advantage audit rule

Use wet bulb globe temperature, not heat index, to protect workers

hotspot

leisure time

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

What American doctors can learn from their Israeli counterparts

Continuity nursing helped my family in our darkest PICU moments

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Psychedelics group wrestles with new pharma identity

After gene therapy, two congenitally deaf children hear for the first time

At least 13 dead in Texas as scorching temps continue

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Trump surgeon general acknowledges mistakes during Covid

leisure time

'Make People Better': The CRISPR babies story you probably don't know

Medicare says breakthrough device reimbursement rule to come by summer

How to improve immunocompromised access to mAb treatments

What American doctors can learn from their Israeli counterparts

What American doctors can learn from their Israeli counterparts

NIH nominee Bertagnolli will get October confirmation hearing

entertainment

leisure time

hotspot

explore